What's in Wouter H. van Geffen's pipeline?

Wouter H. van Geffen has 1 drugs in our index: 1 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Wouter H. van Geffen's portfolio?

Top competitors by shared drug class: AstraZeneca, Fraunhofer-Institute of Toxicology and Experimental Medicine, GlaxoSmithKline, Orion Corporation, Orion Pharma.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/wouter-h-van-geffen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Wouter H. van Geffen — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Wouter H. van Geffen pipeline: 1 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
indacaterol/glycopyrronium 110/50 Breezhaler®	indacaterol/glycopyrronium 110/50 Breezhaler®	marketed	Long-acting beta-2 agonist / Long-acting muscarinic antagonist (LABA/LAMA combination)	Beta-2 adrenergic receptor; Muscarinic M3 acetylcholine receptor	Respiratory / Pulmonology

Therapeutic area mix

Respiratory / Pulmonology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Fraunhofer-Institute of Toxicology and Experimental Medicine · 1 shared drug class
GlaxoSmithKline · 1 shared drug class
Orion Corporation, Orion Pharma · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Wouter H. van Geffen:

Cite this brief

Drug Landscape (2026). Wouter H. van Geffen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/wouter-h-van-geffen. Accessed 2026-05-18.